公司資料
Codexis 股價、新聞與催化劑
- 股票代碼:
- CDXS
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
1.66 USD (-0.60%)
收盤價
最後更新: 2026年8月24日
245M USD
市值
股價為何變動
As of Aug 24, 2026, CDXS closed down 0.60% at $1.66. No new same-company headline was identified in the current news window.
公司概覽
業務概覽
Codexis is an enzyme-engineering company that serves pharma manufacturing, therapeutics, and bioprocessing needs. Its business is built around using protein engineering to solve industrial and healthcare problems.
所在地與產業分類
Headquartered in the United States and listed on NASDAQ, Codexis sits in life-sciences tools and biotech infrastructure.
商業模式特徵
The company depends on platform adoption, customer relationships, and the monetization of engineered enzymes across markets.
生技產業定位
Codexis is a biotech-enabling platform name rather than a drug developer.
未來催化劑
- Codexis’s catalysts are enzyme-engineering partnerships, next-gen biocatalyst demand, and any update that shows the platform is still winning in pharma manufacturing and sequencing workflows. Investors will care about whether recurring platform revenue keeps proving the model works.
近期新聞
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。